Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Edetate disodium is a synthetic chelating agent that binds polyvalent metal ions such as calcium and other divalent or trivalent metals. It is primarily used in emergency medicine for the rapid reduction of dangerously high serum calcium levels (hypercalcemia) and for the control of ventricular arrhythmias associated with digitalis toxicity. By forming stable complexes (chelates) with metal ions in the blood, it facilitates their excretion via urine. Edetate disodium has a wide therapeutic index but must be administered slowly by intravenous infusion to avoid adverse effects such as hypotension or negative cardiac inotropy. It is not absorbed through the skin and also finds use as an excipient and stabilizer in pharmaceutical formulations[1][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on edetate disodium.